Tenet Healthcare (THC) Tops Q2 EPS by 114c; offers guidance

Tenet Healthcare (NYSE: THC) reported Q2 EPS of $4.02, $1.14 better than the analyst estimate of $2.88. Revenue for the quarter came in at $5.27 billion versus the consensus estimate of $5.16 billion.

GUIDANCE:

Tenet Healthcare sees FY2025 EPS of $15.55-$16.21, versus the consensus of $12.83. Tenet Healthcare sees FY2025 revenue of $20.95-21.25 million, versus the consensus of $20.92 million.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance